세계의 LBP(라이브 바이오테라퓨틱스) 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)
Live Biotherapeutics Market, Therapeutic Area and Route of Administration - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1552858
리서치사:Transparency Market Research
발행일:2024년 07월
페이지 정보:영문 141 Pages
라이선스 & 가격 (부가세 별도)
한글목차
LBP(라이브 바이오테라퓨틱스) 시장- 조사 범위
TMR의 조사 보고서 'LBP 세계 시장'은 2024-2034년의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 본 보고서는 2024년을 기준년, 2034년을 예측년으로 하여 2018-2034년 세계 LBP 시장의 수익과 예측을 제공합니다. 또한 2024-2034년 세계 LBP 시장의 복합 연간 성장률(CAGR%)도 제공합니다.
이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 LBP 시장을 추찰했습니다.
시장 현황
2023년 시장 규모
1억 550만 달러
2034년 시장 규모
4억 2,290만 달러
CAGR
14%
이 보고서는 세계 LBP 시장 경쟁 구도를 조사했습니다. 세계의 LBP 시장에서 사업을 전개하는 주요 기업이 확인되고 각 기업은 다양한 속성으로 프로파일 링됩니다. 기업 개요, 재무상황, 최근 동향, SWOT 등이 본 보고서에서 소개되고 있는 세계의 LBP 시장에서의 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약: 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
클로스트리듐 디피실 감염증의 역학
미국에서의 클로스트리듐 디피실 감염증의 동향에 관한 고찰
Porter's Five Forces 분석
제6장 세계 시장 분석과 예측 : 치료 영역별
소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 치료 영역별, 2020-2034년
위장 장애
대사 장애
피부질환
기타
치료 영역별 시장의 매력
제7장 세계 시장 분석과 예측 : 투여 경로별
소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 투여 경로별, 2020-2034년
경구
직장
기타(국소 등)
투여 경로별 시장의 매력
제8장 세계 시장 분석과 예측 : 유통 채널별
소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 유통 채널별, 2020-2034년
병원 약국
소매 약국
온라인 약국
유통채널별 시장의 매력
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 :지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
국가, 지역별 시장의 매력
제10장 북미 시장 분석과 예측
미국
캐나다
제11장 유럽 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
기타 유럽
제12장 아시아태평양 시장 분석과 예측
중국
인도
일본
호주 및 뉴질랜드
기타 아시아태평양
제13장 라틴아메리카 시장 분석과 예측
브라질
멕시코
기타 라틴아메리카
제14장 중동 및 아프리카 시장 분석과 예측
GCC
남아프리카
기타 중동 및 아프리카
제15장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석기업별(2023)
기업 프로파일
Ferring Pharmaceuticals
Seres Therapeutics
Rebiotix Inc.
4D Pharma
Finch Therapeutics
Vedanta Biosciences
Synthetic Biologics
MaaT Pharma
Enterome
Second Genome
JHS
영문 목차
영문목차
Live Biotherapeutics Market - Scope of Report
TMR's report on the global live biotherapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global live biotherapeutics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global live biotherapeutics market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the live biotherapeutics market.
Market Snapshot
Market Value in 2023
US$ 105.5 Mn
Market Value in 2034
US$ 422.9 Mn
CAGR
14%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global live biotherapeutics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global live biotherapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global live biotherapeutics market.
The report delves into the competitive landscape of the global live biotherapeutics market. Key players operating in the global live biotherapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global live biotherapeutics market profiled in this report.
Key Questions Answered in Global live biotherapeutics Market Report:
What is the sales/revenue generated by live biotherapeutics across all regions during the forecast period?
What are the opportunities in the global live biotherapeutics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Live Biotherapeutics Market - Research Objectives and Research Approach
The comprehensive report on the global live biotherapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global live biotherapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global live biotherapeutics market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Live Biotherapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Live Biotherapeutics Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Epidemiology of Clostridium Difficile Infection
5.3. Insights on Trends in the U.S. Burden of Clostridioides Difficile Infection
5.4. Porters' Five Forces Analysis
6. Global Live Biotherapeutics Market Analysis and Forecast, By Therapeutic Area
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Therapeutic Area, 2020-2034
6.3.1. Gastrointestinal Disorders
6.3.2. Metabolic Disorders
6.3.3. Dermatological Diseases
6.3.4. Others
6.4. Market Attractiveness By Therapeutic Area
7. Global Live Biotherapeutics Market Analysis and Forecast, By Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Route of Administration, 2020-2034
7.3.1. Oral
7.3.2. Rectal
7.3.3. Others (Topical etc.)
7.4. Market Attractiveness By Route of Administration
8. Global Live Biotherapeutics Market Analysis and Forecast, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Live Biotherapeutics Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Live Biotherapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Therapeutic Area, 2020-2034
10.2.1. Gastrointestinal Disorders
10.2.2. Metabolic Disorders
10.2.3. Dermatological Diseases
10.2.4. Others
10.3. Market Value Forecast By Route of Administration, 2020-2034
10.3.1. Oral
10.3.2. Rectal
10.3.3. Others (Topical etc.)
10.4. Market Value Forecast By Distribution Channel, 2020-2034
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Therapeutic Area
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Live Biotherapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Therapeutic Area, 2030-2034
11.2.1. Gastrointestinal Disorders
11.2.2. Metabolic Disorders
11.2.3. Dermatological Diseases
11.2.4. Others
11.3. Market Value Forecast By Route of Administration, 2030-2034
11.3.1. Oral
11.3.2. Rectal
11.3.3. Others (Topical etc.)
11.4. Market Value Forecast By Distribution Channel, 2030-2034
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast By Country, 2030-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Therapeutic Area
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country
12. Asia Pacific Live Biotherapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Therapeutic Area, 2031-2034
12.2.1. Gastrointestinal Disorders
12.2.2. Metabolic Disorders
12.2.3. Dermatological Diseases
12.2.4. Others
12.3. Market Value Forecast By Route of Administration, 2031-2034
12.3.1. Oral
12.3.2. Rectal
12.3.3. Others (Topical etc.)
12.4. Market Value Forecast By Distribution Channel, 2031-2034
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast By Country, 2031-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Therapeutic Area
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country
13. Latin America Live Biotherapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Therapeutic Area, 2032-2034
13.2.1. Gastrointestinal Disorders
13.2.2. Metabolic Disorders
13.2.3. Dermatological Diseases
13.2.4. Others
13.3. Market Value Forecast By Route of Administration, 2032-2034
13.3.1. Oral
13.3.2. Rectal
13.3.3. Others (Topical etc.)
13.4. Market Value Forecast By Distribution Channel, 2032-2034
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast By Country, 2032-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Therapeutic Area
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country
14. Middle East & Africa Live Biotherapeutics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Therapeutic Area, 2032-2034
14.2.1. Gastrointestinal Disorders
14.2.2. Metabolic Disorders
14.2.3. Dermatological Diseases
14.2.4. Others
14.3. Market Value Forecast By Route of Administration, 2032-2034
14.3.1. Oral
14.3.2. Rectal
14.3.3. Others (Topical etc.)
14.4. Market Value Forecast By Distribution Channel, 2032-2034
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast By Country, 2032-2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Therapeutic Area
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Ferring Pharmaceuticals
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Seres Therapeutics
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Rebiotix Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. 4D Pharma
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Finch Therapeutics
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Vedanta Biosciences
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Synthetic Biologics
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. MaaT Pharma
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. Enterome
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.10. Second Genome
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
